As of 28 Aug 2026, Marksans Pharma Ltd share price is ₹326.05. The stock opened at ₹326.05 and had closed at ₹330.95 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹156.00 and a high of ₹345.70. In terms of performance, Marksans Pharma Ltd share price has increased by 85.78% over the past six months and has increased by 93.21% over the last year.
MARKSANS Charts
Marksans Pharma Ltd Overview
About MARKSANS
Marksans Pharma engaged in the business of research, manufacture, marketing and selling pharmaceutical formulations. It operates two manufacturing facilities in Goa and maintains two R&D centers; one located in Goa and the other in Navi Mumbai, Maharashtra.
Marksans Pharma Ltd Historical Performance
Marksans Pharma Ltd Fundamental Analysis
Marksans Pharma Ltd Financials
| Indicator | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 |
|---|---|---|---|---|---|
| Revenue | 338.66 | 389.05 | 355.59 | 378.63 | 321.74 |
| EBITDA | 99.58 | 133.47 | 91.31 | 130.27 | 72.06 |
| Net Profit | 69.04 | 91.92 | 60.91 | 99.81 | 48.06 |
| EPS | 1.52 | 2.03 | 1.34 | 2.20 | 1.06 |
Marksans Pharma Ltd Technical Analysis
| Indicator | Value |
|---|---|
| RSI | 68.93 |
| MACD | 17.21 |
| 20-Day SMA | 298.05 |
Marksans Pharma Ltd Corporate Actions
| Corporate Action | Ex Date | Record Date |
|---|---|---|
| No forthcoming board meetings available. | ||
Marksans Pharma Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,913.30+0.73% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,060.00+0.39% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,999.00+2.23% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Marksans Pharma Ltd today is ₹326.05 on NSE and ₹326.05 on BSE.
- The 52-week high of Marksans Pharma Ltd is ₹345.70, while the 52-week low is ₹156.00.
- The current market capitalisation of Marksans Pharma Ltd is approximately ₹14,775 crore.
- The P/E (Price-to-Earnings) ratio of Marksans Pharma Ltd is 21.42. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Marksans Pharma Ltd is 2.88. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To invest in Marksans Pharma Ltd shares,
• Open a Demat and trading account with a registered broker
• Add funds to your account
• Search for Marksans Pharma Ltd on the trading platform
• Place a buy order
• Track your investments - Over the past 3 years, Marksans Pharma Ltd has delivered a return of approximately 194.53%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Marksans Pharma Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 43.87% promoters, 13.10% FIIs, 6.19% DIIs, and 28.05% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
